Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-25109

Single-particle
4.41 Å
EMD-25109 Deposition: 05/10/2021
Map released: 12/10/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25109

Lassa virus glycoprotein construct (Josiah GPC-I53-50A) in complex with LAVA01 antibody

EMD-25109

Single-particle
4.41 Å
EMD-25109 Deposition: 05/10/2021
Map released: 12/10/2022
Last modified: 23/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Lassa mammarenavirus, Oryctolagus cuniculus
Sample: Lassa virus glycoprotein construct(Josiah GPC-I53-50A) in complex with LAVA01 antibody (as Fab fragment)
Fitted models: 7sgf

Deposition Authors: Antanasijevic A, Brouwer PJM
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.
PUBMED: 36400021
DOI: doi:10.1016/j.chom.2022.10.018
ISSN: 1934-6069
Grant Support: